跳至主要内容
临床试验/CTRI/2023/08/056116
CTRI/2023/08/056116Not ApplicableUnknown

A Single-centre, Retrospective, Comparative, Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Vildagliptin 100 mg SR tablet (Jalra-OD®) versus Sitagliptin 100 mg tabletin patients with Type 2 Diabetes Mellitus. - NI

SV Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
Not Applicable
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male or Female subjects of >18 years to <65 years of age diagnosed with type 2 diabetes mellitus.
  • 2. subjects who were on metformin at a stable dose for at least one month before enrolment.
  • 3. Subjects with HbA1c value between =8% - <11%.

排除标准

  • 1. Subjects with known hypersensitivity to any of the components of the formulation.
  • 2. Subjects with a history of Type 1 Diabetes Mellitus.

研究者

发起方
SV Private Limited

相似试验